Latest Myocardial perfusion imaging Stories
SAN DIEGO, June 22, 2011 /PRNewswire/ -- Cardium Therapeutics (NYSE Amex: CXM) today announced the selection of the Cedars-Sinai Medical Center Nuclear Cardiology Core Laboratory (Cedars-Sinai Core Laboratory), Los Angeles, California, to serve as the central core lab for the Company's Generx ASPIRE clinical study.
SAN DIEGO, June 15, 2011 /PRNewswire/ -- Cardium Therapeutics (NYSE Amex: CXM) today announced that it has received clearance from the Russian Ministry of Health and Social Development to commence a Phase 3 registration study for the Company's Generx(TM) (alferminogene tadenovec, Ad5FGF-4) biologic product candidate.
A reduction by half in the radiation dose to which cardiac patients are exposed during diagnostic perfusion imaging is now "feasible", according to an Israeli study.
Cardiac imaging tests, such as CT scans could be putting heart attack patients at a higher risk of cancer.
Exposure to low-dose radiation from cardiac imaging and other procedures after a heart attack is associated with an increased risk of cancer.
Multiple testing with the cardiac diagnostic imaging technique of myocardial perfusion imaging is common, and in many patients is associated with a high cumulative estimated radiation dose.
Molecular imaging of severe heart disease can sometimes lead to false negative results, but doctors can better catch disease with computer analysis of blood flow to the heart.
Study finds that a molecular imaging agent combined with post-scan image processing technology could result in crisper pictures of the heart.
Recommendations could lower radiation exposure in 50% of myocardial perfusion imaging patients by 2014 BETHESDA, Md., June 1 /PRNewswire-USNewswire/ -- New recommendations published by the American Society of Nuclear Cardiology (www.asnc.org) could significantly lower radiation exposure for patients undergoing myocardial perfusion imaging (MPI) procedures.
Special issue of journal explores controversy, calls for more balance.